The objective of the studies is to define novel molecular pathways that regulate hepatocellular injury and death. Employing models of toxic liver injury our underlying hypothesis has been that cell death is not the passive result of the biochemical effects of the toxin but an active process regulated by cell signaling pathways. Studies have focused on how toxic injury alters hepatocyte responses to tumor necrosis factor-? (TNF) and reactive oxygen species (ROS) which are two central mediators of liver injury. Our investigations have delineated the critical involvement of c-Jun N-terminal kinase (JNK) signaling in hepatocyte death from TNF and ROS and in toxic liver injury, and JNK overactivation has been established as a central mechanism of other forms of hepatic injury. However, the mechanisms by which JNK regulates hepatocyte death after injury remain unclear and are complicated by the fact that JNK isoforms function to alternatively promote or resist cell death depending on the nature of the injury. In contrast to prior investigations that focused on JNK's direct involvement in cell death pathways, our studies have identified stathmin and glutaminase as novel JNK substrates and indicate that JNK2 regulation of cell death is mediated through effects on common cellular functions such as microtubule stabilization, glutamine metabolism and autophagy. Based on these and other preliminary studies, our central hypothesis is that JNK2 signaling regulates hepatocyte injury and death predominantly by altering basic cellular processes including cytoskeletal dynamics and metabolism rather than through direct effects on cell death pathway components. We will test this hypothesis by delineating the mechanisms by which JNK regulates hepatocellular injury and death in studies contained in three Specific Aims. First, we will test the hypothesis that JNK2-dependent phosphorylation of stathmin stabilizes microtubules to block hepatocyte death from ROS and TNF. Second, we will test the hypothesis that JNK2 promotes hepatocellular injury by decreasing levels of the glutamine-metabolizing enzyme glutaminase and ammonia generation, thereby reducing autophagy and leading to cell death. Third, we will test the hypothesis that autophagy protects against liver injury through the mobilization of fatty acids that maintains cellular energy homeostasis and inhibits activation of the mitochondrial death pathway. These studies will delineate novel paradigms by which JNK regulation of common cellular pathways leads to profound effects on the sensitivity of hepatocytes to death after cellular injury. The ultimate goal of these investigations is to better understand how hepatocytes are injured and die in order to prevent this process and the development of hepatic failure in human liver diseases.

Public Health Relevance

Acute and chronic liver failure constitutes one of the leading causes of death in the United States. Whatever the etiology of the underlying liver disease, the ultimate cause of hepatic failure is the injury and death of hepatocytes to the extent that there i insufficient liver function for patient survival. It is the objective of this proposal to increase ur understanding of the molecular mechanisms of hepatocyte injury and death in order that new approaches to the prevention of liver failure can be developed.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
5R01DK044234-21
Application #
8702142
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Doo, Edward
Project Start
Project End
Budget Start
Budget End
Support Year
21
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Bronx
State
NY
Country
United States
Zip Code
10461
Zhao, Enpeng; Amir, Muhammad; Lin, Yu et al. (2014) Stathmin mediates hepatocyte resistance to death from oxidative stress by down regulating JNK. PLoS One 9:e109750
Czaja, Mark J; Ding, Wen-Xing; Donohue Jr, Terrence M et al. (2013) Functions of autophagy in normal and diseased liver. Autophagy 9:1131-58
Liu, K; Czaja, M J (2013) Regulation of lipid stores and metabolism by lipophagy. Cell Death Differ 20:3-11
Amir, M; Zhao, E; Fontana, L et al. (2013) Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation. Cell Death Differ 20:878-87
Hernandez-Gea, Virginia; Ghiassi-Nejad, Zahra; Rozenfeld, Raphael et al. (2012) Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142:938-46
Czaja, Mark J (2011) Functions of autophagy in hepatic and pancreatic physiology and disease. Gastroenterology 140:1895-908
Czaja, Mark J (2011) Two types of autophagy are better than one during hepatocyte oxidative stress. Autophagy 7:96-7
Wang, Yongjun; Singh, Rajat; Xiang, Youqing et al. (2010) Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress. Hepatology 52:266-77
Wang, Yongjun; Singh, Rajat; Xiang, Youqing et al. (2010) Nuclear factor ýýB up-regulation of CCAAT/enhancer-binding protein ýý mediates hepatocyte resistance to tumor necrosis factor ýý toxicity. Hepatology 52:2118-26
Wang, Yongjun; Singh, Rajat; Massey, Ashish C et al. (2008) Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus. J Biol Chem 283:4766-77

Showing the most recent 10 out of 40 publications